All Resources | Blog
- All
- Pharmacokinetics & Pharmacodynamics
- Toxicokinetics
- Modeling and Simulation
- Regulatory Affairs
- Study Design and Conduct
- Strategic Advice
- Science News
- Home
- About Us
-
Services
-
In Vitro Screening
- GPCR Screening Services
- Epigenetics Screening Services
- Kinase Screening Services
- Transporter Screening Services
- Ion Channel Screening Services
- HSP90 Screening Services
- Nuclear Receptor Screening Services
- Phosphatase Screening Services
- Phosphodiesterase Screening Services
- Poly (ADP-ribose) Polymerase (PARP) Screening Services
- Protease Screening Services
- Ubiquitin Screening Services
- High Throughput Screening Services
- High Content Screening Services
-
DMPK
-
In Vitro ADME
- Lipophilicity & Solubility
- In Vitro Permeability Assay
- Plasma Stability Assay
- Red Blood Cell Partitioning
- Plasma Protein Binding Assay
- Ligand Binding Assays
- Brain Tissue Binding Assay
- In Vitro Metabolic Stability
- CYP Induction Assay
- CYP Inhibition Assay
- Non-CYP Mediated Metabolism
- Reaction Phenotyping Assay
- Cell Line Panel
- Metabolite Profiling and Identification
- In Vivo PK/PD
- Bioanalytical Services
- BA/BE Services
- Quantitative Tissue Distribution
-
In Vitro ADME
- In Vivo Toxicology
- In Vitro Toxicology
-
In Vitro Screening
-
Solutions
-
By Therapeutic Area
- Oncology Models
- Cardiovascular Disease Models
- Dermatology Models
- Gastrointestinal Disease Models
- Infectious Disease Models
- Inflammatory Disease Models
- Metabolic Disease Models
- Neurology Models
- Ophthalmology Models
- Pain Models
- Renal Disease Models
- Respiratory Disease Models
- Graft versus Host Disease (GvHD) Models
- By Molecule or Product Type
- By Industry
- By Assay Type
-
By Therapeutic Area
- Resource
- Contact Us
